CLARINEX
- Dr Reddy's launches generic antihistamine tablets in USDrug firm Dr Reddy's Laboratories today said it has launched generic antihistamine desloratadine tablets in the American market.
- Ranbaxy falls 7% to nine-month low on USFDA settlement costsAnalysts said Ranbaxy could lose millions of dollars in potential revenues and undergo a time consuming process before it resume supplies
- Sun Pharma receives USFDA nod for generic Clarinex, TiazacSun Pharma has received approval from USFDA for its abbreviated new drug application to market a generic version of Schering Plough's Clari...
- Lupin gets FDA nod for anti-allergic tabletsDrug firm Lupin today said it has been granted final approval by the United states Food and Drug Administration for antihistamine Deslorata...
- Lupin declares litigation settlement with Schering-PloughLupin Ltd has settled all ongoing Hatch-Waxman litigation relating to desloratadine tablets, the generic version of Schering-Plough's Clari...
- Sepracor spanner in Sun Pharma's US planUS-based drug giant Sepracor Inc and the University of Massachusetts have filed a patent infringement suit with the US district court of Ne...
Load More- Lupin gets FDA nod for anti-allergic tablets